123 related articles for article (PubMed ID: 23954480)
21. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.
Pasquali M; Martini P; Shahi A; Jalilian AR; Osso JA; Boschi A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):371-381. PubMed ID: 33026209
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of chemotherapy response in VX2 rabbit lung cancer with 18F-labeled C2A domain of synaptotagmin I.
Wang F; Fang W; Zhang MR; Zhao M; Liu B; Wang Z; Hua Z; Yang M; Kumata K; Hatori A; Yamasaki T; Yanamoto K; Suzuki K
J Nucl Med; 2011 Apr; 52(4):592-9. PubMed ID: 21421722
[TBL] [Abstract][Full Text] [Related]
23. Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator.
Salvarese N; Spolaore B; Marangoni S; Pasin A; Galenda A; Tamburini S; Cicoria G; Refosco F; Bolzati C
J Inorg Biochem; 2018 Jun; 183():18-31. PubMed ID: 29529469
[TBL] [Abstract][Full Text] [Related]
24. Relevance of partially structured states in the non-classical secretion of acidic fibroblast growth factor.
Rajalingam D; Graziani I; Prudovsky I; Yu C; Kumar TK
Biochemistry; 2007 Aug; 46(32):9225-38. PubMed ID: 17636870
[TBL] [Abstract][Full Text] [Related]
25. The calcium-dependent and calcium-independent membrane binding of synaptotagmin 1: two modes of C2B binding.
Kuo W; Herrick DZ; Ellena JF; Cafiso DS
J Mol Biol; 2009 Mar; 387(2):284-94. PubMed ID: 19302798
[TBL] [Abstract][Full Text] [Related]
26. Mechanism for calcium ion sensing by the C2A domain of synaptotagmin I.
Gauer JW; Sisk R; Murphy JR; Jacobson H; Sutton RB; Gillispie GD; Hinderliter A
Biophys J; 2012 Jul; 103(2):238-46. PubMed ID: 22853901
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
Zhang X; Rizo J; Südhof TC
Biochemistry; 1998 Sep; 37(36):12395-403. PubMed ID: 9730811
[TBL] [Abstract][Full Text] [Related]
28. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.
Paterson BM; Donnelly PS
Chem Soc Rev; 2011 May; 40(5):3005-18. PubMed ID: 21409228
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of the C2A domain of synaptotagmin 1: implications for calcium-regulated secretion.
Thomas DM; Elferink LA
J Neurosci; 1998 May; 18(10):3511-20. PubMed ID: 9570782
[TBL] [Abstract][Full Text] [Related]
30. [Re(CO)(3)](+) labelling of a novel cysteine/hexahistidine tag: insights into binding mode by liquid chromatography-mass spectrometry.
Tavaré R; Williams J; Howland K; Blower PJ; Mullen GE
J Inorg Biochem; 2012 Sep; 114():24-7. PubMed ID: 22687562
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.
Alam IS; Neves AA; Witney TH; Boren J; Brindle KM
Bioconjug Chem; 2010 May; 21(5):884-91. PubMed ID: 20402461
[TBL] [Abstract][Full Text] [Related]
32. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.
Baranyai Z; Reich D; Vágner A; Weineisen M; Tóth I; Wester HJ; Notni J
Dalton Trans; 2015 Jun; 44(24):11137-46. PubMed ID: 25999035
[TBL] [Abstract][Full Text] [Related]
33. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
35. The role of the C2A domain of synaptotagmin 1 in asynchronous neurotransmitter release.
Shields MC; Bowers MR; Kramer HL; Fulcer MM; Perinet LC; Metz MJ; Reist NE
PLoS One; 2020; 15(5):e0232991. PubMed ID: 32407359
[TBL] [Abstract][Full Text] [Related]
36. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
37. (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents.
Halder KK; Nayak DK; Baishya R; Sarkar BR; Sinha S; Ganguly S; Debnath MC
Metallomics; 2011 Oct; 3(10):1041-8. PubMed ID: 21833405
[TBL] [Abstract][Full Text] [Related]
38. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
39. Exceptionally tight membrane-binding may explain the key role of the synaptotagmin-7 C
Voleti R; Tomchick DR; Südhof TC; Rizo J
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8518-E8527. PubMed ID: 28923929
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol phosphates as co-activators of Ca2+ binding to C2 domains of synaptotagmin 1.
Li L; Shin OH; Rhee JS; Araç D; Rah JC; Rizo J; Südhof T; Rosenmund C
J Biol Chem; 2006 Jun; 281(23):15845-52. PubMed ID: 16595652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
